| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neurosurgical Procedures | 36 | 2026 | 402 | 12.750 |
Why?
|
| Intracranial Aneurysm | 27 | 2026 | 239 | 9.730 |
Why?
|
| Embolization, Therapeutic | 32 | 2026 | 320 | 8.840 |
Why?
|
| Microsurgery | 20 | 2026 | 120 | 7.260 |
Why?
|
| Cerebral Angiography | 28 | 2026 | 263 | 6.400 |
Why?
|
| Endovascular Procedures | 18 | 2026 | 399 | 6.110 |
Why?
|
| Intracranial Arteriovenous Malformations | 24 | 2026 | 147 | 6.070 |
Why?
|
| Aneurysm, Ruptured | 9 | 2026 | 80 | 3.690 |
Why?
|
| Central Nervous System Vascular Malformations | 9 | 2026 | 57 | 3.670 |
Why?
|
| Cranial Sinuses | 5 | 2026 | 21 | 3.300 |
Why?
|
| Meningeal Arteries | 3 | 2026 | 12 | 2.090 |
Why?
|
| Cerebral Revascularization | 7 | 2026 | 35 | 2.040 |
Why?
|
| Stents | 7 | 2026 | 433 | 1.920 |
Why?
|
| Thalamic Diseases | 2 | 2026 | 6 | 1.920 |
Why?
|
| Central Nervous System Cysts | 2 | 2026 | 11 | 1.900 |
Why?
|
| Treatment Outcome | 55 | 2026 | 9711 | 1.890 |
Why?
|
| Pseudotumor Cerebri | 2 | 2026 | 16 | 1.870 |
Why?
|
| Hematoma, Subdural, Chronic | 2 | 2026 | 6 | 1.860 |
Why?
|
| Middle Aged | 75 | 2026 | 29428 | 1.840 |
Why?
|
| Thalamus | 3 | 2026 | 136 | 1.820 |
Why?
|
| Decompression, Surgical | 4 | 2026 | 171 | 1.820 |
Why?
|
| Humans | 133 | 2026 | 98088 | 1.790 |
Why?
|
| Vertebral Artery | 4 | 2019 | 33 | 1.770 |
Why?
|
| Craniotomy | 9 | 2020 | 100 | 1.760 |
Why?
|
| Neuroendoscopy | 3 | 2026 | 23 | 1.760 |
Why?
|
| Male | 89 | 2026 | 47077 | 1.720 |
Why?
|
| Radial Artery | 3 | 2025 | 41 | 1.720 |
Why?
|
| Spinal Cord | 4 | 2025 | 243 | 1.700 |
Why?
|
| Surgical Instruments | 7 | 2026 | 69 | 1.660 |
Why?
|
| Retrospective Studies | 44 | 2026 | 10973 | 1.630 |
Why?
|
| Radiosurgery | 12 | 2026 | 351 | 1.620 |
Why?
|
| Aged | 49 | 2026 | 21758 | 1.550 |
Why?
|
| Female | 83 | 2026 | 51541 | 1.530 |
Why?
|
| Phlebography | 3 | 2026 | 74 | 1.400 |
Why?
|
| Carotid Artery, Internal | 6 | 2022 | 74 | 1.380 |
Why?
|
| Hemangioma, Cavernous, Central Nervous System | 4 | 2020 | 278 | 1.370 |
Why?
|
| Neuronavigation | 2 | 2026 | 26 | 1.330 |
Why?
|
| Cerebrovascular Disorders | 2 | 2026 | 139 | 1.320 |
Why?
|
| Cervical Vertebrae | 2 | 2026 | 251 | 1.300 |
Why?
|
| Arteriovenous Fistula | 3 | 2020 | 57 | 1.230 |
Why?
|
| Catheters | 4 | 2026 | 109 | 1.200 |
Why?
|
| Third Ventricle | 3 | 2026 | 16 | 1.160 |
Why?
|
| Subarachnoid Hemorrhage | 5 | 2026 | 159 | 1.160 |
Why?
|
| Arteriovenous Malformations | 5 | 2017 | 55 | 1.140 |
Why?
|
| Meningioma | 3 | 2019 | 70 | 1.110 |
Why?
|
| Ulnar Artery | 2 | 2025 | 8 | 1.110 |
Why?
|
| Meningeal Neoplasms | 3 | 2019 | 79 | 1.110 |
Why?
|
| Adult | 52 | 2026 | 29539 | 1.090 |
Why?
|
| Vertebrobasilar Insufficiency | 2 | 2026 | 25 | 1.070 |
Why?
|
| Magnetic Resonance Imaging | 20 | 2026 | 3606 | 1.070 |
Why?
|
| Brain Stem | 4 | 2017 | 167 | 1.060 |
Why?
|
| Cerebellum | 2 | 2019 | 253 | 1.040 |
Why?
|
| Anterior Cerebral Artery | 2 | 2026 | 7 | 1.010 |
Why?
|
| Skull Base Neoplasms | 2 | 2019 | 19 | 0.990 |
Why?
|
| Neuroimaging | 2 | 2026 | 143 | 0.980 |
Why?
|
| Endoscopy | 4 | 2020 | 385 | 0.960 |
Why?
|
| Neoplasms, Neuroepithelial | 1 | 2026 | 5 | 0.960 |
Why?
|
| Carotid-Cavernous Sinus Fistula | 1 | 2026 | 5 | 0.960 |
Why?
|
| Hematoma, Subdural | 1 | 2026 | 30 | 0.950 |
Why?
|
| Balloon Occlusion | 1 | 2026 | 29 | 0.950 |
Why?
|
| Carotid Body Tumor | 1 | 2026 | 4 | 0.950 |
Why?
|
| Cerebral Hemorrhage | 2 | 2020 | 377 | 0.940 |
Why?
|
| Ophthalmic Artery | 2 | 2019 | 8 | 0.940 |
Why?
|
| Arnold-Chiari Malformation | 1 | 2026 | 26 | 0.930 |
Why?
|
| Ossification, Heterotopic | 2 | 2026 | 34 | 0.910 |
Why?
|
| Angiography | 2 | 2025 | 194 | 0.910 |
Why?
|
| Wrist | 1 | 2025 | 30 | 0.910 |
Why?
|
| Temporal Bone | 2 | 2026 | 65 | 0.900 |
Why?
|
| Foramen Magnum | 2 | 2016 | 5 | 0.890 |
Why?
|
| Ventriculostomy | 3 | 2026 | 25 | 0.890 |
Why?
|
| Diverticulum | 1 | 2025 | 45 | 0.860 |
Why?
|
| Intraoperative Neurophysiological Monitoring | 3 | 2021 | 21 | 0.860 |
Why?
|
| Lasers, Gas | 2 | 2014 | 6 | 0.850 |
Why?
|
| Aged, 80 and over | 18 | 2026 | 7389 | 0.840 |
Why?
|
| Upper Extremity | 1 | 2025 | 69 | 0.840 |
Why?
|
| Brain Neoplasms | 4 | 2019 | 839 | 0.800 |
Why?
|
| Young Adult | 26 | 2026 | 7507 | 0.780 |
Why?
|
| Moyamoya Disease | 4 | 2016 | 25 | 0.760 |
Why?
|
| Sella Turcica | 1 | 2022 | 18 | 0.750 |
Why?
|
| Robotics | 1 | 2025 | 271 | 0.740 |
Why?
|
| Middle Cerebral Artery | 2 | 2020 | 24 | 0.730 |
Why?
|
| Machine Learning | 1 | 2026 | 408 | 0.730 |
Why?
|
| Hypoglossal Nerve Diseases | 1 | 2021 | 1 | 0.700 |
Why?
|
| Angiography, Digital Subtraction | 6 | 2026 | 107 | 0.690 |
Why?
|
| Cerebral Veins | 2 | 2025 | 31 | 0.670 |
Why?
|
| Spinal Cord Diseases | 2 | 2020 | 103 | 0.670 |
Why?
|
| Fistula | 1 | 2021 | 44 | 0.670 |
Why?
|
| Neurilemmoma | 1 | 2021 | 39 | 0.660 |
Why?
|
| Angiofibroma | 1 | 2020 | 6 | 0.660 |
Why?
|
| Propensity Score | 9 | 2026 | 213 | 0.640 |
Why?
|
| Seizures | 2 | 2025 | 318 | 0.640 |
Why?
|
| Nasopharyngeal Neoplasms | 1 | 2020 | 48 | 0.630 |
Why?
|
| Magnetic Resonance Angiography | 4 | 2026 | 283 | 0.630 |
Why?
|
| Tinnitus | 3 | 2025 | 31 | 0.630 |
Why?
|
| Quadriplegia | 1 | 2020 | 30 | 0.620 |
Why?
|
| Preoperative Care | 4 | 2026 | 418 | 0.610 |
Why?
|
| Subclavian Steal Syndrome | 1 | 2019 | 2 | 0.610 |
Why?
|
| Blood Loss, Surgical | 1 | 2020 | 140 | 0.610 |
Why?
|
| Patient Discharge | 3 | 2019 | 381 | 0.610 |
Why?
|
| Cranial Fossa, Anterior | 1 | 2019 | 5 | 0.600 |
Why?
|
| Dura Mater | 2 | 2019 | 46 | 0.590 |
Why?
|
| Brain | 7 | 2025 | 2430 | 0.590 |
Why?
|
| Headache Disorders | 1 | 2019 | 7 | 0.590 |
Why?
|
| Gyrus Cinguli | 1 | 2019 | 56 | 0.580 |
Why?
|
| Robotic Surgical Procedures | 1 | 2025 | 411 | 0.570 |
Why?
|
| Cerebral Arteries | 2 | 2020 | 75 | 0.570 |
Why?
|
| Granuloma, Foreign-Body | 1 | 2018 | 7 | 0.570 |
Why?
|
| Cranial Nerves | 2 | 2017 | 9 | 0.560 |
Why?
|
| Equipment Design | 3 | 2026 | 425 | 0.530 |
Why?
|
| Cerebrovascular Circulation | 4 | 2024 | 239 | 0.530 |
Why?
|
| Surgical Mesh | 1 | 2018 | 126 | 0.520 |
Why?
|
| Adolescent | 21 | 2026 | 10080 | 0.510 |
Why?
|
| Carbon Dioxide | 2 | 2014 | 202 | 0.500 |
Why?
|
| Balloon Embolectomy | 1 | 2016 | 1 | 0.480 |
Why?
|
| Optic Chiasm | 1 | 2016 | 17 | 0.470 |
Why?
|
| Pinealoma | 1 | 2016 | 6 | 0.470 |
Why?
|
| Imaging, Three-Dimensional | 6 | 2026 | 630 | 0.470 |
Why?
|
| Pineal Gland | 1 | 2016 | 16 | 0.470 |
Why?
|
| Craniopharyngioma | 1 | 2016 | 13 | 0.470 |
Why?
|
| Postoperative Complications | 7 | 2026 | 2681 | 0.460 |
Why?
|
| Hydrocephalus | 2 | 2026 | 80 | 0.450 |
Why?
|
| Blood-Brain Barrier | 1 | 2016 | 86 | 0.450 |
Why?
|
| Pituitary Neoplasms | 1 | 2016 | 74 | 0.440 |
Why?
|
| Blood Vessel Prosthesis | 3 | 2026 | 255 | 0.440 |
Why?
|
| Heart Arrest | 2 | 2016 | 321 | 0.430 |
Why?
|
| Neurocytoma | 1 | 2014 | 5 | 0.430 |
Why?
|
| Feasibility Studies | 4 | 2026 | 801 | 0.430 |
Why?
|
| Trigeminal Nerve Diseases | 1 | 2014 | 2 | 0.430 |
Why?
|
| Sclerotherapy | 4 | 2015 | 20 | 0.430 |
Why?
|
| Trigeminal Neuralgia | 1 | 2014 | 11 | 0.420 |
Why?
|
| Corpus Callosum | 1 | 2014 | 58 | 0.420 |
Why?
|
| Notochord | 1 | 2014 | 22 | 0.420 |
Why?
|
| Carotid Artery Injuries | 1 | 2014 | 22 | 0.420 |
Why?
|
| Sinus Thrombosis, Intracranial | 1 | 2014 | 22 | 0.420 |
Why?
|
| Drug Delivery Systems | 1 | 2016 | 200 | 0.420 |
Why?
|
| Odontoid Process | 1 | 2014 | 4 | 0.420 |
Why?
|
| Cerebral Ventricles | 1 | 2014 | 66 | 0.420 |
Why?
|
| Chordoma | 1 | 2014 | 44 | 0.400 |
Why?
|
| Epilepsy | 2 | 2015 | 429 | 0.400 |
Why?
|
| Tomography, X-Ray Computed | 8 | 2026 | 2666 | 0.390 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2014 | 104 | 0.390 |
Why?
|
| Glioma | 1 | 2016 | 309 | 0.390 |
Why?
|
| Brain Diseases | 1 | 2014 | 174 | 0.380 |
Why?
|
| Hypertension | 1 | 2019 | 778 | 0.380 |
Why?
|
| Stroke | 7 | 2025 | 1154 | 0.350 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2015 | 238 | 0.350 |
Why?
|
| Dimethyl Sulfoxide | 3 | 2016 | 45 | 0.340 |
Why?
|
| Child | 15 | 2026 | 7681 | 0.340 |
Why?
|
| Databases, Factual | 6 | 2018 | 1094 | 0.320 |
Why?
|
| Abnormalities, Multiple | 1 | 2011 | 235 | 0.310 |
Why?
|
| Fluoroscopy | 3 | 2025 | 138 | 0.310 |
Why?
|
| History, 20th Century | 4 | 2026 | 323 | 0.290 |
Why?
|
| Computed Tomography Angiography | 2 | 2020 | 188 | 0.270 |
Why?
|
| Registries | 4 | 2026 | 1122 | 0.260 |
Why?
|
| Headache | 2 | 2019 | 80 | 0.240 |
Why?
|
| Famous Persons | 2 | 2016 | 10 | 0.240 |
Why?
|
| Drug-Eluting Stents | 1 | 2025 | 24 | 0.230 |
Why?
|
| Orbit | 1 | 2026 | 39 | 0.230 |
Why?
|
| Sclerosing Solutions | 3 | 2015 | 8 | 0.230 |
Why?
|
| Filtration | 1 | 2025 | 26 | 0.230 |
Why?
|
| Cerebrospinal Fluid | 1 | 2025 | 24 | 0.230 |
Why?
|
| Radiation Exposure | 1 | 2025 | 28 | 0.230 |
Why?
|
| Polyvinyls | 2 | 2016 | 23 | 0.220 |
Why?
|
| Quality Improvement | 3 | 2019 | 520 | 0.220 |
Why?
|
| Hemodynamics | 3 | 2019 | 747 | 0.220 |
Why?
|
| Child, Preschool | 7 | 2025 | 4001 | 0.220 |
Why?
|
| Prosthesis Design | 1 | 2026 | 308 | 0.220 |
Why?
|
| Sensitivity and Specificity | 2 | 2026 | 1945 | 0.220 |
Why?
|
| Patient Readmission | 2 | 2019 | 425 | 0.220 |
Why?
|
| Drainage | 1 | 2026 | 176 | 0.220 |
Why?
|
| Retinal Hemorrhage | 1 | 2024 | 10 | 0.220 |
Why?
|
| Antineoplastic Agents | 1 | 2016 | 2373 | 0.210 |
Why?
|
| Intracranial Arteriosclerosis | 1 | 2025 | 74 | 0.210 |
Why?
|
| Fluorescein Angiography | 2 | 2024 | 81 | 0.210 |
Why?
|
| Reperfusion | 1 | 2024 | 33 | 0.210 |
Why?
|
| Carotid Stenosis | 2 | 2021 | 116 | 0.200 |
Why?
|
| Indocyanine Green | 2 | 2020 | 28 | 0.200 |
Why?
|
| Oleic Acids | 2 | 2013 | 33 | 0.200 |
Why?
|
| Contrast Media | 2 | 2026 | 1011 | 0.190 |
Why?
|
| Neurosurgery | 2 | 2015 | 148 | 0.190 |
Why?
|
| Remission, Spontaneous | 2 | 2018 | 45 | 0.170 |
Why?
|
| Frontal Lobe | 2 | 2019 | 128 | 0.170 |
Why?
|
| Smoking | 1 | 2025 | 674 | 0.170 |
Why?
|
| Evoked Potentials, Somatosensory | 2 | 2017 | 20 | 0.160 |
Why?
|
| Diagnosis, Differential | 3 | 2024 | 1567 | 0.160 |
Why?
|
| Carotid Arteries | 1 | 2021 | 132 | 0.160 |
Why?
|
| Mesencephalon | 1 | 2020 | 68 | 0.160 |
Why?
|
| Thrombectomy | 2 | 2021 | 260 | 0.160 |
Why?
|
| Hyperemia | 1 | 2020 | 17 | 0.160 |
Why?
|
| Neck | 3 | 2015 | 103 | 0.150 |
Why?
|
| Endocarditis | 1 | 2020 | 26 | 0.150 |
Why?
|
| Head | 3 | 2015 | 135 | 0.150 |
Why?
|
| Stereotaxic Techniques | 1 | 2020 | 80 | 0.150 |
Why?
|
| Neck Pain | 1 | 2019 | 53 | 0.150 |
Why?
|
| Hemostasis, Surgical | 1 | 2019 | 23 | 0.150 |
Why?
|
| Length of Stay | 3 | 2019 | 878 | 0.150 |
Why?
|
| Cerebral Infarction | 1 | 2019 | 72 | 0.150 |
Why?
|
| Risk Factors | 6 | 2025 | 6233 | 0.140 |
Why?
|
| Textiles | 1 | 2018 | 2 | 0.140 |
Why?
|
| Microcirculation | 1 | 2019 | 101 | 0.140 |
Why?
|
| Temporal Arteries | 2 | 2016 | 10 | 0.140 |
Why?
|
| Perfusion Imaging | 1 | 2019 | 52 | 0.140 |
Why?
|
| Optical Imaging | 1 | 2019 | 55 | 0.140 |
Why?
|
| Logistic Models | 2 | 2019 | 1275 | 0.140 |
Why?
|
| Hematinics | 1 | 2018 | 12 | 0.140 |
Why?
|
| Ferrosoferric Oxide | 1 | 2018 | 19 | 0.140 |
Why?
|
| Comorbidity | 3 | 2019 | 1033 | 0.140 |
Why?
|
| Perioperative Period | 1 | 2018 | 31 | 0.140 |
Why?
|
| Facial Neuralgia | 1 | 2018 | 2 | 0.140 |
Why?
|
| Intraoperative Complications | 1 | 2019 | 194 | 0.140 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2020 | 192 | 0.130 |
Why?
|
| Mitral Valve Insufficiency | 1 | 2020 | 179 | 0.130 |
Why?
|
| Neurophysiological Monitoring | 1 | 2017 | 19 | 0.130 |
Why?
|
| Hematoma | 1 | 2018 | 106 | 0.130 |
Why?
|
| Safety Management | 1 | 2018 | 54 | 0.130 |
Why?
|
| Brain Infarction | 1 | 2017 | 23 | 0.130 |
Why?
|
| Choroid Diseases | 1 | 2017 | 5 | 0.130 |
Why?
|
| Infant | 5 | 2025 | 3328 | 0.130 |
Why?
|
| Brain Ischemia | 2 | 2019 | 416 | 0.130 |
Why?
|
| Lumbar Vertebrae | 1 | 2021 | 376 | 0.130 |
Why?
|
| Population Surveillance | 1 | 2018 | 218 | 0.130 |
Why?
|
| Reflex, Trigeminocardiac | 1 | 2016 | 2 | 0.120 |
Why?
|
| Functional Laterality | 1 | 2017 | 199 | 0.120 |
Why?
|
| Elective Surgical Procedures | 1 | 2018 | 171 | 0.120 |
Why?
|
| Cerebral Arterial Diseases | 1 | 2016 | 8 | 0.120 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2018 | 121 | 0.120 |
Why?
|
| Hospitalization | 2 | 2019 | 991 | 0.120 |
Why?
|
| Arachnoid | 1 | 2016 | 5 | 0.120 |
Why?
|
| Follow-Up Studies | 5 | 2025 | 4025 | 0.120 |
Why?
|
| Anticoagulants | 1 | 2020 | 486 | 0.120 |
Why?
|
| Age Factors | 3 | 2016 | 1962 | 0.120 |
Why?
|
| Equipment Failure Analysis | 1 | 2016 | 88 | 0.120 |
Why?
|
| Noonan Syndrome | 1 | 2016 | 10 | 0.120 |
Why?
|
| Liver Diseases | 1 | 2018 | 249 | 0.120 |
Why?
|
| Enbucrilate | 1 | 2015 | 9 | 0.120 |
Why?
|
| Algorithms | 1 | 2024 | 2002 | 0.120 |
Why?
|
| Cyanoacrylates | 1 | 2015 | 7 | 0.120 |
Why?
|
| Perioperative Care | 1 | 2018 | 198 | 0.120 |
Why?
|
| Inpatients | 2 | 2016 | 369 | 0.110 |
Why?
|
| Hemostatics | 1 | 2016 | 64 | 0.110 |
Why?
|
| Dissection | 1 | 2016 | 48 | 0.110 |
Why?
|
| Hypothalamus | 1 | 2016 | 82 | 0.110 |
Why?
|
| Prejudice | 1 | 2015 | 51 | 0.110 |
Why?
|
| Face | 1 | 2016 | 116 | 0.110 |
Why?
|
| Plaque, Amyloid | 1 | 2015 | 69 | 0.110 |
Why?
|
| Combined Modality Therapy | 2 | 2021 | 1751 | 0.110 |
Why?
|
| Skull Base | 1 | 2016 | 55 | 0.110 |
Why?
|
| Patient Safety | 1 | 2018 | 235 | 0.110 |
Why?
|
| Social Isolation | 1 | 2015 | 73 | 0.110 |
Why?
|
| Vascular Malformations | 1 | 2015 | 19 | 0.110 |
Why?
|
| Femoral Artery | 1 | 2015 | 96 | 0.110 |
Why?
|
| Syncope | 1 | 2014 | 31 | 0.110 |
Why?
|
| Microvascular Decompression Surgery | 1 | 2014 | 4 | 0.110 |
Why?
|
| Leg | 1 | 2015 | 145 | 0.110 |
Why?
|
| Facial Pain | 1 | 2014 | 12 | 0.110 |
Why?
|
| Animals | 4 | 2026 | 28904 | 0.110 |
Why?
|
| Cranial Fossa, Posterior | 1 | 2014 | 24 | 0.100 |
Why?
|
| Pliability | 1 | 2014 | 6 | 0.100 |
Why?
|
| Sensation Disorders | 1 | 2014 | 33 | 0.100 |
Why?
|
| Purinergic P2Y Receptor Antagonists | 1 | 2014 | 11 | 0.100 |
Why?
|
| Cerebrum | 1 | 2014 | 15 | 0.100 |
Why?
|
| Thrombelastography | 1 | 2014 | 48 | 0.100 |
Why?
|
| Lymphatic Abnormalities | 1 | 2013 | 10 | 0.100 |
Why?
|
| Intensive Care Units | 1 | 2018 | 520 | 0.100 |
Why?
|
| Vasospasm, Intracranial | 1 | 2014 | 38 | 0.100 |
Why?
|
| Radiography | 1 | 2015 | 764 | 0.100 |
Why?
|
| Heparin | 1 | 2014 | 182 | 0.100 |
Why?
|
| Angioplasty, Balloon | 1 | 2014 | 91 | 0.100 |
Why?
|
| Ischemia | 1 | 2015 | 262 | 0.100 |
Why?
|
| Monitoring, Intraoperative | 1 | 2014 | 115 | 0.100 |
Why?
|
| Acute Lung Injury | 1 | 2014 | 74 | 0.100 |
Why?
|
| Surgeons | 1 | 2018 | 325 | 0.090 |
Why?
|
| Prospective Studies | 5 | 2025 | 4823 | 0.090 |
Why?
|
| Actins | 1 | 2016 | 480 | 0.090 |
Why?
|
| Skull | 1 | 2015 | 278 | 0.090 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2014 | 304 | 0.090 |
Why?
|
| Fibrinolytic Agents | 1 | 2014 | 242 | 0.090 |
Why?
|
| Cohort Studies | 2 | 2016 | 3212 | 0.090 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2014 | 194 | 0.090 |
Why?
|
| Neoadjuvant Therapy | 1 | 2016 | 478 | 0.090 |
Why?
|
| Ophthalmoscopes | 1 | 2011 | 3 | 0.090 |
Why?
|
| Paresthesia | 1 | 2011 | 24 | 0.090 |
Why?
|
| Computer Simulation | 1 | 2016 | 1147 | 0.090 |
Why?
|
| Vision Disorders | 1 | 2011 | 71 | 0.080 |
Why?
|
| Reoperation | 1 | 2014 | 727 | 0.080 |
Why?
|
| United States | 4 | 2018 | 8197 | 0.080 |
Why?
|
| Biomedical Research | 1 | 2015 | 471 | 0.080 |
Why?
|
| Multiple Sclerosis | 1 | 2012 | 268 | 0.080 |
Why?
|
| Vein of Galen Malformations | 1 | 2009 | 2 | 0.080 |
Why?
|
| Alzheimer Disease | 1 | 2015 | 646 | 0.080 |
Why?
|
| Carotid Artery, Internal, Dissection | 2 | 2021 | 34 | 0.080 |
Why?
|
| Pediatrics | 1 | 2014 | 421 | 0.070 |
Why?
|
| Spinal Fusion | 1 | 2014 | 372 | 0.070 |
Why?
|
| Severity of Illness Index | 1 | 2014 | 2013 | 0.070 |
Why?
|
| Predictive Value of Tests | 3 | 2019 | 1782 | 0.070 |
Why?
|
| Pregnancy | 1 | 2016 | 3244 | 0.070 |
Why?
|
| Program Evaluation | 2 | 2018 | 346 | 0.060 |
Why?
|
| History, 15th Century | 2 | 2015 | 7 | 0.060 |
Why?
|
| History, 16th Century | 2 | 2015 | 10 | 0.060 |
Why?
|
| History, 17th Century | 2 | 2015 | 14 | 0.060 |
Why?
|
| History, Medieval | 2 | 2015 | 14 | 0.060 |
Why?
|
| History, 18th Century | 2 | 2015 | 23 | 0.060 |
Why?
|
| History, 19th Century | 2 | 2015 | 57 | 0.060 |
Why?
|
| History, Ancient | 2 | 2015 | 84 | 0.060 |
Why?
|
| Multivariate Analysis | 2 | 2019 | 1009 | 0.050 |
Why?
|
| History, 21st Century | 2 | 2015 | 196 | 0.050 |
Why?
|
| Social Class | 1 | 2025 | 156 | 0.050 |
Why?
|
| Emergency Service, Hospital | 2 | 2019 | 634 | 0.050 |
Why?
|
| Ultrasonography | 2 | 2019 | 720 | 0.050 |
Why?
|
| Socioeconomic Factors | 1 | 2025 | 663 | 0.050 |
Why?
|
| Pennsylvania | 1 | 2022 | 108 | 0.040 |
Why?
|
| Walruses | 1 | 2021 | 1 | 0.040 |
Why?
|
| Carotid Artery, Common | 1 | 2021 | 28 | 0.040 |
Why?
|
| Arteriosclerosis | 1 | 2021 | 107 | 0.040 |
Why?
|
| Carotid Artery Diseases | 1 | 2021 | 101 | 0.040 |
Why?
|
| Incidence | 1 | 2025 | 1779 | 0.040 |
Why?
|
| Intracranial Hemorrhages | 1 | 2021 | 138 | 0.040 |
Why?
|
| Coloring Agents | 1 | 2019 | 70 | 0.040 |
Why?
|
| Spectrum Analysis | 1 | 2019 | 119 | 0.040 |
Why?
|
| Blood Flow Velocity | 1 | 2019 | 179 | 0.040 |
Why?
|
| Thrombosis | 1 | 2021 | 318 | 0.040 |
Why?
|
| Work Engagement | 1 | 2018 | 8 | 0.030 |
Why?
|
| Subclavian Artery | 1 | 2018 | 43 | 0.030 |
Why?
|
| Time Factors | 2 | 2019 | 5567 | 0.030 |
Why?
|
| Prognosis | 1 | 2026 | 4116 | 0.030 |
Why?
|
| Evidence-Based Practice | 1 | 2018 | 54 | 0.030 |
Why?
|
| Incidental Findings | 1 | 2018 | 100 | 0.030 |
Why?
|
| Mortality | 1 | 2018 | 159 | 0.030 |
Why?
|
| ROC Curve | 1 | 2019 | 794 | 0.030 |
Why?
|
| Central Nervous System Venous Angioma | 1 | 2016 | 1 | 0.030 |
Why?
|
| Government | 1 | 2016 | 11 | 0.030 |
Why?
|
| Russia | 1 | 2016 | 29 | 0.030 |
Why?
|
| Ear | 1 | 2016 | 18 | 0.030 |
Why?
|
| Hospitals | 1 | 2019 | 336 | 0.030 |
Why?
|
| Leadership | 1 | 2018 | 159 | 0.030 |
Why?
|
| United Kingdom | 1 | 2016 | 208 | 0.030 |
Why?
|
| Basilar Artery | 1 | 2015 | 42 | 0.030 |
Why?
|
| Evoked Potentials, Motor | 1 | 2015 | 30 | 0.030 |
Why?
|
| Retreatment | 1 | 2015 | 107 | 0.030 |
Why?
|
| Alberta | 1 | 2014 | 11 | 0.030 |
Why?
|
| Parietal Lobe | 1 | 2015 | 114 | 0.030 |
Why?
|
| Prasugrel Hydrochloride | 1 | 2014 | 8 | 0.030 |
Why?
|
| Ticlopidine | 1 | 2014 | 25 | 0.030 |
Why?
|
| Ischemic Attack, Transient | 1 | 2016 | 195 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2018 | 1950 | 0.030 |
Why?
|
| Health Facility Size | 1 | 2014 | 12 | 0.030 |
Why?
|
| Monitoring, Physiologic | 1 | 2015 | 263 | 0.030 |
Why?
|
| Survival Rate | 1 | 2018 | 2041 | 0.020 |
Why?
|
| International Classification of Diseases | 1 | 2014 | 74 | 0.020 |
Why?
|
| Disease Management | 1 | 2016 | 377 | 0.020 |
Why?
|
| Bias | 1 | 2014 | 139 | 0.020 |
Why?
|
| Aspirin | 1 | 2014 | 169 | 0.020 |
Why?
|
| Rural Population | 1 | 2014 | 191 | 0.020 |
Why?
|
| Urban Population | 1 | 2014 | 246 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2014 | 764 | 0.020 |
Why?
|
| Hippocampus | 1 | 2015 | 462 | 0.020 |
Why?
|
| Recurrence | 1 | 2015 | 1254 | 0.020 |
Why?
|
| Prevalence | 1 | 2014 | 1384 | 0.020 |
Why?
|
| Sepsis | 1 | 2014 | 427 | 0.020 |
Why?
|
| Biomarkers | 1 | 2015 | 2020 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2016 | 2585 | 0.020 |
Why?
|
| Mutation | 1 | 2016 | 4396 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2009 | 2529 | 0.010 |
Why?
|
| Heart Failure | 1 | 2009 | 1491 | 0.010 |
Why?
|